Cargando…
Schisandrin B inhibits tumor progression of hepatocellular carcinoma by targeting the RhoA/ROCK1 pathway
BACKGROUND: Schisandrin B (Sch. B) performs various pharmacological properties, including anticancer activities. However, the pharmacological mechanisms of Sch. B in hepatocellular carcinoma (HCC) are not fully elucidated. We investigated the impact and mechanism on progression in HCC, and to provid...
Autores principales: | Yang, Hui, Wu, Tengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186521/ https://www.ncbi.nlm.nih.gov/pubmed/37201042 http://dx.doi.org/10.21037/jgo-23-87 |
Ejemplares similares
-
The RhoA-ROCK pathway in the regulation of T and B cell responses
por: Ricker, Edd, et al.
Publicado: (2016) -
Progression of Human Renal Cell Carcinoma via Inhibition of RhoA-ROCK Axis by PARG1()()
por: Miyazaki, Junichiro, et al.
Publicado: (2017) -
SHROOM2 inhibits tumor metastasis through RhoA–ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma
por: Yuan, Jing, et al.
Publicado: (2019) -
Brusatol Inhibits Proliferation and Metastasis of Colorectal Cancer by Targeting and Reversing the RhoA/ROCK1 Pathway
por: Lu, Rui-jin, et al.
Publicado: (2022) -
A TRANSCRIPTIONAL CROSS–TALK BETWEEN RhoA AND c–Myc INHIBITS THE RhoA/Rock–DEPENDENT CYTOSKELETON
por: Sauzeau, Vincent, et al.
Publicado: (2010)